JS
Jwalant Sureshbhai Shah
About Jwalant Sureshbhai Shah
Data last updated:
Jwalant Sureshbhai Shah is a Whole-Time Director at Unipath Specialty Laboratory Limited (since 2009), Director at Ravula Unipath Health Care Private Limited (since 2025) and Director at Simira Unipath Diagnostics Private Limited (since 2024), and holds 20 more current directorships. The companies operate in Healthcare. The 5 current companies with reported revenue have a combined latest revenue of ₹265 Cr; the largest is Unipath Specialty Laboratory Limited at ₹183 Cr (FY 2024). Earlier, Jwalant Sureshbhai Shah was a Designated Partner at Unidrg Specialty Laboratory Llp (2021–2024) and Designated Partner at Octa Specialty Laboratory Llp (2021–2023) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unipath Specialty Laboratory Limited U85195GJ2009PLC057059 | Whole-Time Director | 26 May 2009 | 2009 | ₹183 Cr (FY 2024) | Active |
 Ravula Unipath Health Care Private Limited U86905TS2023PTC172315 | Director | 27 May 2025 | 2023 | ₹55.55 Cr (FY 2025) | Active |
| Simira Unipath Diagnostics Private Limited U85190MH2020PTC335458 | Director | 06 Jan 2024 | 2020 | ₹14.78 Cr (FY 2024) | Active |
 Advanced Transfusion Medicine Research Foundation U19129GJ1997NPL032264 | Director | 27 Feb 2012 | 1997 | ₹7.50 Cr (FY 2022) | Active |
| Designated Partner | 06 Nov 2019 | 2019 | ₹3.30 Cr (FY 2023) | Active | |
| Unipath Specialty Laboratory (Baroda) Private Limited U86905GJ2025PTC170911 | Director | 19 Dec 2025 | 2025 | Active | |
| Dr. Sanjay Mehta Unipath Speciality Laboratory Private Limited U86905MH2024PTC435523 | Director | 27 Nov 2024 | 2024 | Active | |
| Bioscape Healthspan Private Limited U86905GJ2024PTC154541 | Director | 20 Aug 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Unidrg Specialty Laboratory Llp AAZ-4713 | Designated Partner | 15 Nov 2021 | 2021 | Active | |
| Octa Specialty Laboratory Llp AAV-9429 | Designated Partner | 17 Feb 2021 | 2021 | Active | |
| Designated Partner | 01 Aug 2025 | 2019 | ₹24.27 Cr (FY 2023) | Converted And Dissolved |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jwalant Sureshbhai Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jwalant Sureshbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jwalant Sureshbhai Shah
Jwalant Sureshbhai Shah currently holds 23 directorships: Unipath Specialty Laboratory Limited (Whole-Time Director, since 26 May 2009, revenue ₹183 Cr (FY 2024)); Ravula Unipath Health Care Private Limited (Director, since 27 May 2025, revenue ₹55.55 Cr (FY 2025)); Simira Unipath Diagnostics Private Limited (Director, since 06 Jan 2024, revenue ₹14.78 Cr (FY 2024)); Advanced Transfusion Medicine Research Foundation (Director, since 27 Feb 2012, revenue ₹7.50 Cr (FY 2022)); Kansagara Unipath Specialty Laboratory Llp (Designated Partner, since 06 Nov 2019, revenue ₹3.30 Cr (FY 2023)); and 18 more.
Jwalant Sureshbhai Shah was first appointed on 26 May 2009 as Whole-Time Director at Unipath Specialty Laboratory Limited. The most recent appointment on record is 19 Dec 2025 at Unipath Specialty Laboratory (Baroda) Private Limited.
The 5 current companies of Jwalant Sureshbhai Shah that report revenue have a combined latest revenue of ₹265 Cr: Unipath Specialty Laboratory Limited ₹183 Cr (FY 2024); Ravula Unipath Health Care Private Limited ₹55.55 Cr (FY 2025); Simira Unipath Diagnostics Private Limited ₹14.78 Cr (FY 2024); Advanced Transfusion Medicine Research Foundation ₹7.50 Cr (FY 2022); Kansagara Unipath Specialty Laboratory Llp ₹3.30 Cr (FY 2023).
Jwalant Sureshbhai Shah held 3 earlier board appointments: Unidrg Specialty Laboratory Llp (Designated Partner, 15 Nov 2021 to 01 Jul 2024); Octa Specialty Laboratory Llp (Designated Partner, 17 Feb 2021 to 01 Oct 2023); Unipath Specialty Laboratory (Baroda) Llp (Designated Partner, from 01 Aug 2025).
The current boards of Jwalant Sureshbhai Shah's companies include Abhishek Rawka (Unipath Specialty Laboratory Limited), Mahesh Tarachand Mohatta (Unipath Specialty Laboratory Limited), Prema Mani Iyer (Unipath Specialty Laboratory Limited), Rushabh Dilipkumar Sanghavi (Unipath Specialty Laboratory Limited), Urmish Hasmukh Chudgar (Unipath Specialty Laboratory Limited), Harish Chandra Reddy (Ravula Unipath Health Care Private Limited), among others.